Wells Fargo’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-747,822
| Closed | -$3.86M | – | 6468 |
|
2019
Q2 | $3.86M | Sell |
747,822
-202,179
| -21% | -$1.04M | ﹤0.01% | 2776 |
|
2019
Q1 | $3.42M | Buy |
950,001
+208,733
| +28% | +$751K | ﹤0.01% | 2887 |
|
2018
Q4 | $4.54M | Sell |
741,268
-5,806
| -0.8% | -$35.6K | ﹤0.01% | 2500 |
|
2018
Q3 | $4.36M | Buy |
747,074
+61,315
| +9% | +$358K | ﹤0.01% | 2728 |
|
2018
Q2 | $2.92M | Buy |
685,759
+46,323
| +7% | +$197K | ﹤0.01% | 3108 |
|
2018
Q1 | $2.82M | Buy |
639,436
+177,824
| +39% | +$784K | ﹤0.01% | 3067 |
|
2017
Q4 | $2.43M | Buy |
461,612
+94,247
| +26% | +$496K | ﹤0.01% | 3177 |
|
2017
Q3 | $2.25M | Buy |
367,365
+63,377
| +21% | +$389K | ﹤0.01% | 3166 |
|
2017
Q2 | $2.2M | Buy |
303,988
+27,836
| +10% | +$201K | ﹤0.01% | 3110 |
|
2017
Q1 | $1.46M | Buy |
276,152
+203,738
| +281% | +$1.08M | ﹤0.01% | 3412 |
|
2016
Q4 | $520K | Buy |
72,414
+44,717
| +161% | +$321K | ﹤0.01% | 4063 |
|
2016
Q3 | $259K | Sell |
27,697
-9,370
| -25% | -$87.6K | ﹤0.01% | 4175 |
|
2016
Q2 | $234K | Buy |
37,067
+5,092
| +16% | +$32.1K | ﹤0.01% | 4179 |
|
2016
Q1 | $176K | Buy |
31,975
+21,199
| +197% | +$117K | ﹤0.01% | 4341 |
|
2015
Q4 | $61K | Buy |
10,776
+700
| +7% | +$3.96K | ﹤0.01% | 5015 |
|
2015
Q3 | $85K | Buy |
10,076
+989
| +11% | +$8.34K | ﹤0.01% | 4816 |
|
2015
Q2 | $138K | Buy |
9,087
+7,308
| +411% | +$111K | ﹤0.01% | 4668 |
|
2015
Q1 | $29K | Buy |
1,779
+247
| +16% | +$4.03K | ﹤0.01% | 5046 |
|
2014
Q4 | $28K | Buy |
1,532
+209
| +16% | +$3.82K | ﹤0.01% | 5028 |
|
2014
Q3 | $13K | Sell |
1,323
-8,637
| -87% | -$84.9K | ﹤0.01% | 5316 |
|
2014
Q2 | $155K | Buy |
9,960
+1,951
| +24% | +$30.4K | ﹤0.01% | 4401 |
|
2014
Q1 | $149K | Buy |
8,009
+7,609
| +1,902% | +$142K | ﹤0.01% | 4394 |
|
2013
Q4 | $8K | Buy |
+400
| New | +$8K | ﹤0.01% | 5116 |
|